Cipla Limited — Updates, 04-08-2026: General Updates
04-08-2026 | 08:57 am
04-08-2026 | 08:57 am
Cipla's US subsidiary, InvaGen, received an Establishment Inspection Report (EIR) from the USFDA for its New York facility, indicating the successful closure of the inspection. This clears a key regulatory hurdle for new product approvals.
No comments yet. Be the first to comment!
